Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson’s disease trial

Fig. 1

Quantitative evaluation of DaT-SPECT striatal binding ratio (SBR). aWhole putamen SBR, b most affected putamen SBR, and c demographically indexed most affected putamen SBR of participants in SPARK categorised by qualitative visual assessment as “abnormal” or “normal.” Demographic indexing normalises metrics to published normal SBR values based on age and sex [42]. Red cross indicates the mean value

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us